Update on Recently FDA Approved Belimumab for Lupus Nephritis: What Are the Response Rates and Toxicity Profile? What Are the Current Filgotinib Efficacy Updates for RA?

Login

Password

Forgot your password?

Join VuMedi

Select specialty

First name

Last name

Choose Password

About Us
Careers
Partner with us
F.A.Q
Contact us
Terms & conditions
Privacy policy

RheumNow

RheumNow is a news and education source dedicated to rheumatology, founded by rheumatologist Dr. Jack Cush.
Daily we publish content developed by experts, which includes news items, blogs, videos, podcasts, meeting coverage and more. Rheumatologists and other interested physicians and health professionals are invited to visit us at RheumNow.com.